Cellectar Biosciences Inc (CLRB)

CONSUMER DISCRETIONARY: CONSUMER SERVICES
SIC: PHARMACEUTICAL PREPARATIONS

100 CAMPUS DRIVE FLORHAM PARK, NJ 07932

Cellectar Biosciences is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company is developing proprietary drugs independently and through research and development collaborations. The company's core objective is to leverage its proprietary Phospholipid Drug Conjugateâ„¢ (PDC) delivery platform to develop PDCs that specifically target cancer cells, delivering improved efficacy and better safety as a result of fewer off-target effects. The company's PDC platform possesses the potential for the discovery and development of the next-generation of cancer-targeting treatments, and it plans to develop PDCs independently and through research and development collaborations. The company's product pipeline includes one preclinical PDC chemotherapeutic program (CLR 1900) and multiple partnered PDC assets.

Data as of 2021-07-25 16:35:40 -0400
Market Cap59.053 Million Shares Outstanding52.726 Million Avg 30-day Volume1.292 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.19 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.57516 52-week High/Low2.98 / 1.01 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -9.5998
Data provided by IEX Cloud
View SEC Filings from CLRB instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 46 41 12.2% 17 (1.0%) 17 (0.99%) 0.0%
13F shares: 15.044 Million 17.68 Million -14.91% 10.528 Million 11.483 Million -8.32%
% Ownership 29.7875 38.9353 -23.49% 20.8463 25.288 -17.56%
New Positions: 16 25 -36.0% 6 13 -53.85%
Increased Positions 12 6 100.0% 4 2 100.0%
Closed Positions 11 6 83.33% 6 2 200.0%
Reduced Positions 6 2 200.0% 4 1 300.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CLRB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLRB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NEIS JOHN

  • Director
78,000 2021-06-30 3

LOREN STEFAN

  • Director
78,000 2021-06-30 1

SWIRSKY DOUGLAS J

  • Director
117,000 2021-06-30 1

DRISCOLL FREDERICK W

  • Director
78,000 2021-06-30 1

CHANAN-KHAN ASHER

  • Director
78,000 2021-06-30 2

CARUSO JAMES V PRESIDENT AND CEO

  • Officer
  • Director
1,686,401 2021-03-04 2

LONGCOR JARROD CHIEF BUSINESS OFFICER

  • Officer
450,000 2021-03-04 2

FRIEND JOHN E. II CHIEF MEDICAL OFFICER

  • Officer
330,000 2021-03-04 1

ELEFANT DOV CHIEF FINANCIAL OFFICER

  • Officer
430,000 2021-03-04 2

HILL STEPHEN A

  • Director
0 2020-06-24 0

GRACHEV IGOR D CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-06 0

BERNHARDT CHARLES THOMAS III INTERIM CFO

  • Officer
0 2019-03-09 0

POSNER BRIAN M CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-17 0

HAMILL JOHN P. INTERIM CFO

  • Officer
0 2017-09-05 0

KOLEAN CHAD J VP, CHIEF FINANCIAL OFFICER

  • Officer
80,000 2017-04-18 0

HERTZBERG RICHARD

  • SIGNIFICANT OWNER
No longer subject to file 2016-08-09 0

WEICHERT JAMEY P CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-05-12 0

BERNS PAUL L

  • Director
117,371 2016-04-20 0

WISCONSIN ALUMNI RESEARCH FOUNDATION

  • 10% Owner
469,484 2016-04-14 0

AWM INVESTMENT COMPANY, INC.

  • 10% Owner
No longer subject to file 2015-12-30 0

GENN JOHN PATRICK VP OF BUSINESS DEVELOPMENT

  • Officer
0 2015-02-26 0

MARXE AUSTIN W & GREENHOUSE DAVID M

  • 10% Owner
1,142,368 2015-02-03 0

SZAKACS CAMERON VP OF CLINICAL DEVELOPMENT

  • Officer
0 2014-11-24 0

PEDDER SIMON PRESIDENT AND CEO

  • Officer
  • Director
13,300 2014-08-20 0

CORMORANT ASSET MANAGEMENT, LLC

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE GP, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

  • Director
  • 10% Owner
530,000 2014-08-15 0

MCNEIL KATHRYN M SEE REMARKS

  • Officer
0 2014-08-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SWIRSKY DOUGLAS J - Director

2021-07-02 16:04:10 -0400 2021-06-30 A 117,000 a 117,000 direct

NEIS JOHN - Director

2021-07-02 16:03:32 -0400 2021-06-30 A 78,000 a 78,000 direct

CHANAN-KHAN ASHER - Director

2021-07-02 16:02:34 -0400 2021-06-30 A 78,000 a 78,000 direct

LOREN STEFAN - Director

2021-07-02 16:03:32 -0400 2021-06-30 A 78,000 a 78,000 direct

DRISCOLL FREDERICK W - Director

2021-07-02 16:03:06 -0400 2021-06-30 A 78,000 a 78,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 17:15:03 UTC -15.5986 15.6786 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 16:45:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 16:15:02 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 15:45:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 15:15:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 14:45:02 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 14:15:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 13:45:02 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 13:15:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-28 12:45:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 22:15:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 21:45:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 21:15:03 UTC -16.1103 16.1903 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 20:45:03 UTC -16.3985 16.4785 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 20:15:03 UTC -16.3985 16.4785 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 19:45:02 UTC -16.3985 16.4785 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 19:15:02 UTC -16.3985 16.4785 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 18:45:03 UTC -16.3985 16.4785 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 18:15:02 UTC -16.3985 16.4785 1500000
CELLECTAR BIOSCIENCES INC CLRB 2021-07-27 17:45:03 UTC -16.3985 16.4785 1500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments